| Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms G Meola, R Cardani Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (4), 594-606, 2015 | 369 | 2015 |
| Common micro‐RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia S Greco, M De Simone, C Colussi, G Zaccagnini, P Fasanaro, M Pescatori, ... The FASEB Journal 23 (10), 3335-3346, 2009 | 300 | 2009 |
| Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1 R Perbellini, S Greco, G Sarra-Ferraris, R Cardani, MC Capogrossi, ... Neuromuscular Disorders 21 (2), 81-88, 2011 | 144 | 2011 |
| Deregulated microRNAs in myotonic dystrophy type 2 S Greco, A Perfetti, P Fasanaro, R Cardani, MC Capogrossi, G Meola, ... PloS one 7 (6), e39732, 2012 | 105 | 2012 |
| Plasma microRNAs as biomarkers for myotonic dystrophy type 1 A Perfetti, S Greco, E Bugiardini, R Cardani, P Gaia, C Gaetano, G Meola, ... Neuromuscular Disorders 24 (6), 509-515, 2014 | 84 | 2014 |
| Covid-19-associated coagulopathy: biomarkers of thrombin generation and fibrinolysis leading the outcome M Ranucci, C Sitzia, E Baryshnikova, U Di Dedda, R Cardani, F Martelli, ... Journal of clinical medicine 9 (11), 3487, 2020 | 80 | 2020 |
| Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2 A Vihola, LL Bachinski, M Sirito, SE Olufemi, S Hajibashi, KA Baggerly, ... Acta neuropathologica 119, 465-479, 2010 | 78 | 2010 |
| Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2 R Cardani, E Mancinelli, G Rotondo, V Sansone, G Meola European Journal of Histochemistry 50 (3), 177-182, 2006 | 75 | 2006 |
| CRISPR/Cas9-mediated deletion of CTG expansions recovers normal phenotype in myogenic cells derived from myotonic dystrophy 1 patients C Provenzano, M Cappella, R Valaperta, R Cardani, G Meola, F Martelli, ... Molecular Therapy-Nucleic Acids 9, 337-348, 2017 | 71 | 2017 |
| Myotonic dystrophy type 2: an update on clinical aspects, genetic and pathomolecular mechanism G Meola, R Cardani Journal of neuromuscular diseases 2 (s2), S59-S71, 2015 | 71 | 2015 |
| Biomolecular identification of (CCTG) n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy R Cardani, E Mancinelli, V Sansone, G Rotondo, G Meola European Journal of Histochemistry 48 (4), 437-442, 2004 | 67 | 2004 |
| Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 A Perfetti, S Greco, R Cardani, B Fossati, G Cuomo, R Valaperta, ... Scientific reports 6 (1), 38174, 2016 | 65 | 2016 |
| Activation of the Pro-Oxidant PKCβII-p66Shc Signaling Pathway Contributes to Pericyte Dysfunction in Skeletal Muscles of Patients With Diabetes With Critical Limb … R Vono, C Fuoco, S Testa, S Pirrò, D Maselli, D Ferland McCollough, ... Diabetes 65 (12), 3691-3704, 2016 | 54 | 2016 |
| SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype E Bugiardini, I Rivolta, A Binda, AS Caminero, F Cirillo, A Cinti, ... Neuromuscular disorders 25 (4), 301-307, 2015 | 52 | 2015 |
| Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2 R Cardani, M Giagnacovo, A Botta, F Rinaldi, A Morgante, B Udd, ... Journal of neurology 259, 2090-2099, 2012 | 52 | 2012 |
| Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects G Meola, R Cardani Neurological Sciences 38, 535-546, 2017 | 47 | 2017 |
| Muscle biopsy G Meola, E Bugiardini, R Cardani Journal of neurology 259, 601-610, 2012 | 46 | 2012 |
| Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2 R Cardani, E Bugiardini, LV Renna, G Rossi, G Colombo, R Valaperta, ... PLoS One 8 (12), e83777, 2013 | 43 | 2013 |
| Antibody responses to BNT162b2 mRNA vaccine: infection‐naïve individuals with abdominal obesity warrant attention AE Malavazos, S Basilico, G Iacobellis, V Milani, R Cardani, F Boniardi, ... Obesity 30 (3), 606-613, 2022 | 39 | 2022 |
| Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction LV Renna, R Cardani, A Botta, G Rossi, B Fossati, E Costa, G Meola European journal of histochemistry: EJH 58 (4), 2014 | 39 | 2014 |
